News and Updates
Early results from CanPath’s national study confirm antibody levels are stronger after receiving two doses of COVID-19 vaccine
Jun 23, 2021 // Study Updates
Initial preliminary results from the Canadian Partnership for Tomorrow’s Health (CanPath) COVID-19 Antibody Study, based on close to 6,000 dried blood spot samples collected between February 8 and May 17, 2021, show a high degree of variability in the level of antibodies produced by a single dose of a COVID-19 vaccine. These findings highlight the importance of
Ontario Health Study begins whole genome sequencing to enrich data holdings
Apr 5, 2021 // Study Updates
The Ontario Health Study is launching an initiative to sequence the whole genomes of more than 40,000 participants from across Ontario. Samples from more than 9,600 Study participants have already been genotyped, using the UKBIObank Affymetrix arrays. Whole genome sequencing, which measures an individual’s entire genome, will provide additional information that will complement the existing
The Ontario Health Study (OHS): a resource for cancer etiology and early marker studies
Mar 26, 2021 // Study Updates
In this prospective cohort study of 225,620 participants, 10,436 incident cancers were ascertained over an average 8-yr follow-up, including 1,645 breast, 907 lung, 840 colorectal, 509 bladder, 227 pancreatic, and 181 ovarian cancer cases. The proportion of cancers diagnosed at stage III/IV was highest for pancreatic (69%) and oral (69%), followed by lung (66%),
The Effect of COVID-19 on Cancer Patients and Survivors
Mar 26, 2021 // Study Updates
Cancer patients and survivors perceive a high risk of being harmed by COVID-19 and were more likely to adopt preventive measures; they were less likely to contract the virus, perhaps as a result. The pandemic has presented the healthcare delivery system with unprecedented challenges, profoundly affecting cancer patients, and has catalyzed the rapid adoption
